26 reports of this reaction
2.1% of all DEXTROMETHORPHAN POLISTIREX reports
#9 most reported adverse reaction
CONDITION AGGRAVATED is the #9 most commonly reported adverse reaction for DEXTROMETHORPHAN POLISTIREX, manufactured by Haleon US Holdings LLC. There are 26 FDA adverse event reports linking DEXTROMETHORPHAN POLISTIREX to CONDITION AGGRAVATED. This represents approximately 2.1% of all 1,242 adverse event reports for this drug.
Patients taking DEXTROMETHORPHAN POLISTIREX who experience condition aggravated should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
CONDITION AGGRAVATED is a less commonly reported adverse event for DEXTROMETHORPHAN POLISTIREX, but still significant enough to appear in the safety profile.
In addition to condition aggravated, the following adverse reactions have been reported for DEXTROMETHORPHAN POLISTIREX:
The following drugs have also been linked to condition aggravated in FDA adverse event reports:
CONDITION AGGRAVATED has been reported as an adverse event in 26 FDA reports for DEXTROMETHORPHAN POLISTIREX. This does not prove causation, but indicates an association observed in post-market surveillance data.
CONDITION AGGRAVATED accounts for approximately 2.1% of all adverse event reports for DEXTROMETHORPHAN POLISTIREX, making it a notable side effect.
If you experience condition aggravated while taking DEXTROMETHORPHAN POLISTIREX, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.